GMO International Qualit... Aktie - QLTI

Professionelle Tools für Privatanleger.

Premium

Current Price

24,3193

Gebot

Fragen

Volumen

0,00 Tagesbereich 0,00

22,49 52-Wochen-Bereich 25,46

Handelsende

24,3193

Handelsbeginn

Letzte Trade

Letzter Handelszeitpunkt

Durchschnittliches Volumen (3 Mio.)

23.820

Finanzvolumen

VWAP

QLT Inc. establishes sales force in the United States

- QLT Ophthalmics, Inc. will market Visudyne(R) to retinal specialists across the U.S.- VANCOUVER, Dec. 22 /PRNewswire-FirstCall/ -- QLT Inc...

QLT initiates Phase Ib study of QLT091001 in Leber Congenital Amaurosis

VANCOUVER, Dec. 15 /PRNewswire-FirstCall/ -- QLT Inc. (NASDAQ: QLTI; TSX: QLT) ("QLT" or the "Company") today announced that it has initiated...

6-month results from EVEREST study evaluating Visudyne(R) therapy in patients with polypoidal choroidal vasculopathy

VANCOUVER, Dec. 9 /PRNewswire-FirstCall/ -- QLT Inc. (NASDAQ: QLTI; TSX: QLT) ("QLT" or the "Company") welcomed the 6-month results from the...

QLT announces MGH litigation settlement

VANCOUVER, Nov. 25 /PRNewswire-FirstCall/ -- QLT Inc. (NASDAQ: QLTI; TSX: QLT) ("QLT" or the "Company") today announced the settlement of its...

QLT announces Toronto Stock Exchange approval of share repurchase program

VANCOUVER, Oct. 28 /PRNewswire-FirstCall/ -- QLT Inc. (NASDAQ: QLTI; TSX: QLT) ("QLT") announced that the Toronto Stock Exchange ("TSX") has...

QLT Announces Share Repurchase Program

VANCOUVER, Oct. 27 /PRNewswire-FirstCall/ -- QLT Inc. (NASDAQ: QLTI; TSX: QLT) ("QLT" or the "Company") today announced that its board of...

QLT announces third quarter results for 2009

QLT SEPARATELY ANNOUNCES SHARE REPURCHASE PROGRAM VANCOUVER, Oct. 27 /PRNewswire-FirstCall/ -- QLT Inc. (NASDAQ: QLTI; TSX: QLT) ("QLT" or the...

QLT restructures Visudyne(R) agreement

RECEIVES EXCLUSIVE U.S. RIGHTS AND WILL RECEIVE A ROYALTY ON SALES OUTSIDE THE U.S. VANCOUVER, Oct. 19 /PRNewswire-FirstCall/ -- QLT Inc...

QLT announces sale of QLT USA, Inc. for up to US$230 million

VANCOUVER, Oct. 1 /PRNewswire-FirstCall/ -- QLT Inc. (NASDAQ: QLTI; TSX: QLT) ("QLT" or the "Company") today announced that it has completed the...

QLT announces receipt of a CDN$45.3 million tax refund

VANCOUVER, Sept. 8 /PRNewswire-FirstCall/ -- QLT Inc. (NASDAQ: QLTI; TSX: QLT) ("QLT" or the "Company") today announced that it has received an...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	-0.6207	-2.48877305533	24.94	25.0984	24.21	129505	24.69245227	SP
4	-0.1407	-0.575224856909	24.46	25.35	24.15	39854	24.67118574	SP
12	1.1093	4.77940542869	23.21	25.46	22.49	23820	24.13314428	SP
26	-0.5307	-2.13561368209	24.85	25.46	22.49	17979	24.07815995	SP
52	-0.5307	-2.13561368209	24.85	25.46	22.49	17979	24.07815995	SP
156	-0.5307	-2.13561368209	24.85	25.46	22.49	17979	24.07815995	SP
260	-0.5307	-2.13561368209	24.85	25.46	22.49	17979	24.07815995	SP

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
L09Lithium Energi Exploration Inc	0,02 € (66,67%)	126,56k
VOPInvestigator Resources Ltd	0,0175 € (40,00%)	4,79k
IAHInternational Lithium Corp	0,0145 € (38,10%)	20,1k
E47Falcon Metals Ltd	0,0752 € (26,60%)	22,5k
OU5AAvalon Advanced Materials Inc	0,022 € (23,60%)	100k
GTYGateway Real Estate AG	0,15 € (-50,00%)	20,99k
9COCorus Entertainment	0,0335 € (-43,70%)	460
97E0Vizsla Copper Corp	0,0322 € (-32,35%)	47
E3O1Nexoptic Technology Corp	0,006 € (-29,41%)	6,15k
36GGBM Resources Limited	0,004 € (-27,27%)	17,89k
D7GNel ASA	0,3001 € (-5,48%)	25,59M
RQ0DWave Quantum Inc	5,61 € (5,41%)	1,11M
UH7ATennant Minerals NL	0,008 € (6,67%)	1,08M
WIG1Wige Media AG	0,02 € (-24,53%)	1,02M
TKAThyssenkrupp AG	8,834 € (0,84%)	984,49k

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

GMO International Quality ETF (QLTI)

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

QLTI Neueste Nachrichten

QLT Inc. establishes sales force in the United States

QLT initiates Phase Ib study of QLT091001 in Leber Congenital Amaurosis

6-month results from EVEREST study evaluating Visudyne(R) therapy in patients with polypoidal choroidal vasculopathy

QLT announces MGH litigation settlement

QLT announces Toronto Stock Exchange approval of share repurchase program

QLT Announces Share Repurchase Program

QLT announces third quarter results for 2009

QLT restructures Visudyne(R) agreement

QLT announces sale of QLT USA, Inc. for up to US$230 million

QLT announces receipt of a CDN$45.3 million tax refund

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

GMO International Quality ETF (QLTI) Börsenkurse

GMO International Quality ETF (QLTI)

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

QLTI Neueste Nachrichten

QLT Inc. establishes sales force in the United States

QLT initiates Phase Ib study of QLT091001 in Leber Congenital Amaurosis

6-month results from EVEREST study evaluating Visudyne(R) therapy in patients with polypoidal choroidal vasculopathy

QLT announces MGH litigation settlement

QLT announces Toronto Stock Exchange approval of share repurchase program

QLT Announces Share Repurchase Program

QLT announces third quarter results for 2009

QLT restructures Visudyne(R) agreement

QLT announces sale of QLT USA, Inc. for up to US$230 million

QLT announces receipt of a CDN$45.3 million tax refund

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen